This data also demonstrated significantly increased expression of co-inhibitory molecule TNFRSF14 (HVEM) in peritumoral breast cancer LECs compared to normal breast LECs, consistent with our findings in B16F10- bearing mice (Table S1). This evidence concerns the gene TNFRSF14 and breast cancer.